Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Eloflex AB
AB
Active
Org 5590715164
Hammarbacken 4b, Box 435, 191 24
Sollentuna
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2016 · 9 years old
6 employees
Overvåg
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Eloflex AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (4)
JO
Jonas Oscar Jonathan Alexandersson
External Signatory
External Signatory
2025
MK
Maria Kristina Johansson
External Signatory
External Signatory
2020
CH
Carl-Johan Henrik Kjellman
Chief Auditor
Chief Auditor
2023
AL
Anna Linnea Möller
Chief Executive Officer
Chief Executive Officer
2025
Former (5)
JU
Johan Ulf Lennart Adlén
Chief Executive Officer
Chief Executive Officer
2020 – 2025
CE
Carina Elna Strid
External Signatory
External Signatory
2023 – 2024
SK
Susanna Kristin Helgesen
External Signatory
External Signatory
2021 – 2022
JM
Joanna Mikaela Sofi Daugaard
Chief Executive Officer
Chief Executive Officer
2020 – 2020
NP
Nils Peter Åsheim
Audit
Audit
2020 – 2023
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (3)
CM
Carl Martin Lagerberg
Chairman
Chairman
2026
HJ
Hans Johan Steene
Deputy Board Member
Deputy Board Member
2026
AK
Anna-Karin Karlsson
Board of Directors
Board of Directors
2020
Former (6)
DD
Diandian Daniel Sun Zhang
Board of Directors
Board of Directors
2021 – 2024
NK
Nils Kjell Nicklas Wigren
Board of Directors
Board of Directors
2020 – 2021
DV
Dan Vigand Nilsson
Board of Directors
Board of Directors
2020 – 2020
MH
Mona Henrika Axman
Chairman
Chairman
2020 – 2021
LC
Lars Christer Torgny Udd
Board of Directors
Board of Directors
2020 – 2020
JO
Jonas Olov Häggqvist
Deputy Board Member
Deputy Board Member
2020 – 2020
Aktionærer
Pr. seneste årsrapport
Shareholder
Type
Ownership
Votes
Since
Teqnion AB
Company
100%
100%
0001
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Eloflex AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network